I-2 Can we bypass a muscle metabolic defect?

Por Argov, Z.
Publicado em 2011

Drug-induced peripheral neuropathies.

Por Argov, Z, Mastaglia, F L
Publicado em 1979

Familial inflammatory demyelinating polyneuropathy: a Guillain-Barré syndrome variant without autoimmune predilection.

Por Korn-Lubetzki, I, Steiner, I, Brenner, T, Brautbar, C, Argov, Z
Publicado em 1994

Effects of thyroid hormones on skeletal muscle bioenergetics. In vivo phosphorus-31 magnetic resonance spectroscopy study of humans and rats.

Por Argov, Z, Renshaw, P F, Boden, B, Winokur, A, Bank, W J
Publicado em 1988

Mitochondrial myopathy with atypical subacute presentation

Por COHEN, O., STEINER, I., ARGOV, Z., ASHKENAZI, A., DIMENT, J., SAADA, A., RIVER, Y.
Publicado em 1998

Antibiotic induced meningitis.

Por River, Y, Averbuch-Heller, L, Weinberger, M, Meiner, Z, Mevorach, D, Schlesinger, I, Argov, Z
Publicado em 1994

Common mutations in the phosphofructokinase-M gene in Ashkenazi Jewish patients with glycogenesis VII--and their population frequency.

Por Sherman, J. B., Raben, N., Nicastri, C., Argov, Z., Nakajima, H., Adams, E. M., Eng, C. M., Cowan, T. M., Plotz, P. H.
Publicado em 1994